ImmuneBridge logo

ImmuneBridge Funding & Investors

San Francisco, CA

ImmuneBridge is developing allogeneic immunotherapies for cancer. ImmuneBridge's key innovation fosters the development of immune stem cells obtained from cord blood and creates a fresh, adaptable, reliable, and plentiful cellular source for immunotherapies. They are currently looking for natural ki... Read more

immunebridge.com

Total Amount Raised: $17,632,000

ImmuneBridge's Investors

ImmuneBridge Funding Rounds

  • Series Unknown

    $5,632,000

  • Seed

    $12,000,000

    Seed Investors

    Insight Venture Partners
    M Ventures
    One Way Ventures
    Gaingels
Funding info provided by Diffbot.